City’s largest share sale in four years shows Beijing’s determination to push China’s EV technologies worldwide, analysts say ...

Singapore-based medical testing firm Mirxes joins Jiangsu Hengrui Pharmaceuticals in revitalised market’s listing surge.

Trading in the shares is expected to start on May 23. Read more at straitstimes.com. Read more at straitstimes.com.

SINGAPORE] Singapore biotech start-up Mirxes launched its initial public offering (IPO) in Hong Kong on Thursday (May 15) as ...

SINGAPORE] Companies have been flocking to file applications for initial public offerings (IPOs) in Hong Kong amid ...

Hong Kong is calling for robotaxi operator Pony AI . The $6 billion Chinese company is exploring an offering in the city just ...

The Chinese battery giant’s secondary offering would be the biggest listing in Hong Kong this year.

Law firms may want to rethink the pivot from Hong Kong to the U.S., given Trump’s tariffs have made way for a potential thaw ...

China’s Zijin Mining Group (OTCPK:ZIJMF) (OTCPK:ZIJMY) has picked Citic Securities Co. and Morgan Stanley (MS) to lead the ...

This digital payment services provider is likely to get a lift from China's initiatives to boost domestic consumption.

(Reuters) -Chinese drug developer and producer Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a ...

Xpeng Inc. is considering an initial public offering for its flying car unit, Xpeng Aeroht, according to people familiar with ...